Cancer interception with KRAS inhibitors in preclinical models of pancreatic ductal adenocarcinoma.
Saved in:
| Title: | Cancer interception with KRAS inhibitors in preclinical models of pancreatic ductal adenocarcinoma. |
|---|---|
| Authors: | Than, Minh T.1,2 (AUTHOR), Dequiedt, Lucie3 (AUTHOR), Sor, Rina2 (AUTHOR), Nair, Shreya1,2 (AUTHOR), Markosyan, Nune1,2 (AUTHOR), Furth, Emma E.4 (AUTHOR), Yang, Chenghua2 (AUTHOR), Ray-Fofana, Courtney2 (AUTHOR), Menard, Marie5 (AUTHOR), Quintana, Elsa5 (AUTHOR), Edwards, A. Cole2 (AUTHOR), Hennessey, Connor J.2 (AUTHOR), Good, Austin L.2 (AUTHOR), Quinones, Liz2 (AUTHOR), Hwang, Yunseo3 (AUTHOR), Clendenin, Cynthia2 (AUTHOR), Kiemen, Ashley L.3,6,7,8 (AUTHOR), Vonderheide, Robert H.1,2 (AUTHOR) rhv@upenn.edu, Stanger, Ben Z.1,2 (AUTHOR) bstanger@upenn.edu |
| Source: | Science. 3/12/2026, Vol. 391 Issue 6790, p1161-1166. 6p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
